Home > Healthcare > Biotechnology > Biotechnology R&D > Human Microbiome Market

Human Microbiome Market Share

Report ID: GMI6538
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Human Microbiome Market Share

Major market players operating in the human microbiome market include

Seres Therapeutics
Enterome
Second Genome Inc.
DuPont
Synthetic Biologics, Inc.
Synlogic
Vedanta Biosciences, Inc.
Metabiomics Corporation
Microbiome Therapeutics LLC
4D pharma plc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The Global market value for human microbiome was USD 824.4 million in 2023 and is expected to reach USD 6.47 billion by 2032, backed by the growing prevalence of lifestyle-related diseases.

The digestive tract segment held largest market share of 31.9% in 2022 and will continue growing by 2032 due to the increasing awareness of the pivotal role that the gut microbiome plays in overall health.

North America market revenue was USD 261.2 million in 2022 and is anticipated to record around 24.9% CAGR between 2023-2032 attributed to the advancements in microbiome research and growing emphasis on personalized medicine in the region.

Seres Therapeutics, Enterome, Second Genome Inc., DuPont, Synthetic Biologics, Inc., Synlogic, Vedanta Biosciences, Inc., Metabiomics Corporation, Microbiome Therapeutics LLC, and 4D pharma plc. among others.